Think Greek yogurt, cottage cheese, eggs, chicken soup, rice bowls, turkey slices, tuna, protein shakes, and soft potatoes
GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) but their most recent incarnations, which consist of both next generation GLP-1s and combinations (Ozempic, Mounjaro, Wegovy, Zepbound), have moved beyond the realm of T2D into the treatment of obesity
For sicker patients with established cardiovascular disease, Wegovy is definitely the way to go it can lower the risk of a recurrent event, and in this situation, phentermine is inappropriate
reta a.k.a
A bottom-up approach was used to estimate and validate the total size of the GLP-1 Agonists market
Depending on how much you have to lose, the extra weight can be gone in a few weeks or months